Your browser version may not work well with NCBI's Web applications. More information here...
1: Peptides. 2004 Apr;25(4):543-9.Click here to read Links

A potential antitumor peptide therapeutic derived from antineoplastic urinary protein.

Hehir KM, Baguisi A, Pennington SE, Bates JM, DiTullio PA.

TranXenoGen Inc., Technology Development, 800 Boston Turnpike, Shrewsbury, MA 01545, USA. khehir@tranxenogen.com

New therapies in cancer treatment are focusing on multifaceted approaches to starve and kill tumors utilizing both antiangiogenic and chemotherapeutic compounds. Antineoplastic Urinary Protein (ANUP), a 32k Da protein normally secreted in human urine, has been previously described as a molecule possessing both antiproliferative and antiangiogenic activities. Two synthetic peptides complimentary to the N-terminus of ANUP were designed to test their ability to reproduce these beneficial effects but ultimately to provide a more useful small molecule therapeutic. The results show that the peptides reduced tumor burden by up to 70% in a nude mouse model and demonstrated the ability to inhibit blood vessel formation in a chick chorioallantoic membrane assay (CAM). Copyright 2004 Elsevier Inc.

PMID: 15165708 [PubMed - indexed for MEDLINE]